Navigation Links
EntreMed ENMD-2076 Phase 2 Data to Be Presented at ASCO Annual Meeting
Date:5/19/2011

ROCKVILLE, Md., May 19, 2011 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer today announced the presentation of clinical data for its Phase 2 study with ENMD-2076 in platinum-resistant ovarian cancer patients.  The data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting to be held June 3 - 7, 2011 in Chicago, Illinois.

(Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO)-

Gynecologic Cancer Track: Poster SessionFriday, June 3, 2011 – 2:00 p.m. - 6:00 p.m. (CDT) Abstract No.: 5021Title: A Phase 2 Study of ENMD-2076 in platinum-resistant ovarian cancer Poster Board: 10, Location: E450aDiscussion SessionFriday, June 3, 2011 – 5:00 p.m. - 6:00 p.m. (CDT)Location: E354bAbout ENMD-2076ENMD-2076 is an orally-active, Aurora A/angiogenic kinase inhibitor with a unique kinase selectivity profile and multiple mechanisms of action. Preclinical studies with ENMD-2076 demonstrated significant antitumor activity, including tumor regression, in multiple solid and hematological malignancies. ENMD-2076 has been shown to inhibit a distinct profile of angiogenic tyrosine kinase targets in addition to the Aurora A kinase. Aurora kinases are key regulators of mitosis (cell division), and are often over-expressed in human cancers. ENMD-2076 also targets the VEGFR, Flt-3 and FGFR3 kinases which have been shown to play important roles in the pathology of several cancers. While ENMD-2076 is currently in a Phase 2 trial in ovarian cancer, preclinical and clinical activities are ongoing in assessing the compound's applicability in other forms of cancer.

About EntreMedEntreMed, Inc. is a clinical-stage pharmaceutical company committed to developing ENMD-2076, a selective angiogenic kinase inhibitor, for the treatment of cancer.  
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
2. EntreMed Raises $20 Million to Support Clinical Development Program
3. EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198
4. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
5. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
6. EntreMed to Present at The New York Society of Security Analysts Industry Conference
7. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
8. EntreMed Commences Continuous Dosing Clinical Trial For MKC-1
9. EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
10. EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR Annual Meeting
11. EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... , April 24, 2015   Vestagen Technical ... technology, VESTEX ® , has recently received two notable ... a global competition that recognizes innovations with potential to ... ceremony last night in New York City ... the Material Science "Protection & Safety" category. The awards ...
(Date:4/24/2015)... Apr. 24, 2015 Research and Markets ... the addition of the "Lab Accessories ... Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station) & End User (OEM/Biotechnology ... Forecast to 2020" report to their ... market is expected to reach $504.7 million ...
(Date:4/24/2015)... , April 24, 2015 Hi-Tech Pharmaceuticals ... was not the product of reliable scientific principles ... reliable basis for allegations of adulteration. The FDA ... a false premise, or misguided hope, that Methylphenylethylamine ... studies are contradicted by multiple other studies and ...
Breaking Medicine Technology:VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 2VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 3Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 2Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 3Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 2Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 3Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 4Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 5Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 6
... Kimberly-Clark Corporation (NYSE: KMB ) announced today ... business, which includes a number of innovative, minimally-invasive radio-frequency ... the exclusive distributor of Baylis Medical,s pain management products ... improves the competitive position of Kimberly-Clark Health Care in ...
... Oct. 5 US Oncology, Inc. ... (EHR) system, iKnowMed , at the American ... EHR Symposium: Harnessing the EHR: From Incentives to Sustainability ... iKnowMed(TM) addresses the unique needs of community-based medical oncologists. The ...
Cached Medicine Technology:Kimberly-Clark Acquires Baylis Medical Company's Pain Management Business 2Kimberly-Clark Acquires Baylis Medical Company's Pain Management Business 3US Oncology, Inc. to Exhibit iKnowMed(TM) at the 2009 ASCO EHR Symposium: Harnessing the EHR: From Incentives to Sustainability 2US Oncology, Inc. to Exhibit iKnowMed(TM) at the 2009 ASCO EHR Symposium: Harnessing the EHR: From Incentives to Sustainability 3
(Date:4/25/2015)... (PRWEB) April 25, 2015 For thirteen years, ... premier income protection education event in the nation! This year, ... The Plus Group, US to take DI Day on the ... George G. Davidson, CLU, ChFC, RHU, DIA, CLTC, Chief Executive ... DI Day reflects on the change by stating, "The first ...
(Date:4/24/2015)... York, NY (PRWEB) April 24, 2015 ... sober living residence in Westchester County. Just 35 miles ... help transition individuals back into everyday life while recovering ... Thursday, May 7, 2015, will allow therapists, doctors and ... areas and learn more about the opportunities offered by ...
(Date:4/24/2015)... 24, 2015 As the nation recognizes ... unique sacrifices of these young men and women, the ... Veterans and their Families” presents a special training session ... to gain a better understanding of the effect of ... For those – civilian and military – who provide ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 Carvers' ... to have a successful biking day in Breck. ... just five minutes walking distance from Breckenridge, this ... well-versed in both Breckenridge bike rentals ( http://www.breckenridgeskishop.com/en/rent-equipment ... to offer extensive bike rentals in May 2015. ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 Lipitor ... forward in the federal multidistrict litigation underway in ... to court documents, the parties involved in the ... 16th detailing, among other things, preparation for the ... counsel for both plaintiffs and defendants have conducted ...
Breaking Medicine News(10 mins):Health News:Secura Consultants Takes DI Day On The Road 2Health News:Constellations Recovery Opens The First Luxury Sober Living Residence in Westchester New York 2Health News:Constellations Recovery Opens The First Luxury Sober Living Residence in Westchester New York 3Health News:Coalition Presents Resiliency Training to Raise Awareness during Month of the Military Child (#MOTMC2015) 2Health News:Carvers Breckenridge Bike Rentals Offers Demo Mountain, Tandem, Bike Path Cruiser & JR. Bikes in May 2015 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 3
... Corporation,(NYSE: SYK ) announced today a series of ... bench and position it for continued,success., Si Johnson, ... successful 29-year career with Stryker. It would be,impossible to ... Stryker over,these years, but what is very clear is ...
... HEPA filter lasting 6-9 months with continuous daily use ... including a UV lamp life that kills airborne bacteria ... in the United States made with absolutely no lead ... 24-hour programmable Paralda is the most powerful and energy ...
... advance screening and clinical research available nationwide, BETHESDA, ... Diabetes Day (Nov. 14) -- Diabetes in Children and ... Johnson. Diagnosed,with type 1 diabetes at age 19, she ... her disease are about 1 in 25., Due ...
... 10 MGT Capital Investments,Inc. (Amex: MGT ... Healthcare,Information Technology ("HCIT") sector, today reported financial results,for ... provided an update on,strategic milestones., Tim Paterson-Brown, ... of 2008 Medicsight continues to make progress towards ...
... Sponsored by Little Tikes, the Afternoon Raised Money and Awareness for ... ... 10 Hundreds of families,joined hosts Jenny McCarthy and Joely Fisher ... Social Club on,Sunday, November 9, 2008. Founded by Harvard graduates Michael ...
... Join the leading pharma executives redefining the ... challenges of driving,world class procurement, LONDON, ... times,pharmaceutical organisations are dramatically re-evaluating their business,models. ... is greater than,ever and board of directors ...
Cached Medicine News:Health News:Stryker Announces Organizational and Leadership Changes 2Health News:Stryker Announces Organizational and Leadership Changes 3Health News:Stryker Announces Organizational and Leadership Changes 4Health News:For the First Time this Winter Consumers Have an Electronic Green Solution that Eliminates 99.97 Percent of Indoor Air Pollution 2Health News:Former Miss America Nicole Johnson Takes Action for Type 1 Diabetes Research 2Health News:MGT Capital Investments Reports Third Quarter 2008 Financial Results and Provides Update on Recent Developments 2Health News:MGT Capital Investments Reports Third Quarter 2008 Financial Results and Provides Update on Recent Developments 3Health News:TotSpot.com Celebrates Launch With Jenny McCarthy, Joely Fisher, Tori Spelling and Other Celebrity Mommies at The Treehouse Social Club 2Health News:CPhI Conferences to Present Pharma Procurement Leadership Summit on December 10, 2008 in London 2
... ULTRAVIST (iopromide) injection is ... agent for intravascular administration. Introduced in ... after becoming available in Europe, ULTRAVIST ... 75 countries. It has established a ...
The Mitek Restore System, designed in conjunction with Sanford S. Kunkel, M.D., offers instrumentation for all ACL Procedures....
The cordless Simon Dermatome with rechargeable battery is used to harvest split-thickness skin grafts and for debridement....
... quality and innovation has resulted in one ... Model C is an air dermatome especially ... in burn care surgery. The Model C ... same dedication to quality, durability and reliability ...
Medicine Products: